» Articles » PMID: 34351000

Mortality of People with Parkinson's Disease in a Large UK-Based Cohort Study: Time Trends and Relationship to Disease Duration

Overview
Journal Mov Disord
Date 2021 Aug 5
PMID 34351000
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parkinson's disease (PD) is associated with increased mortality, but little is known about changes over time, and relationship to disease progression.

Objectives: To explore how PD mortality rates have changed over time and their relationship to disease duration and demographics using a large population-based cohort in the UK.

Methods: We included individuals aged 50+ years with a first recording of PD diagnosis and at least two prescriptions of any antiparkinsonian drug actively registered within a general practice from 2006 to 2016 and up to six frequency-matched controls from The Health Improvement Network (THIN) database. We estimated adjusted mortality rates using multivariable Poisson regression.

Results: A total of 10,104 people with a diagnosis of PD and 55,664 people without PD were included. Overall, PD was associated with slightly increased mortality compared to non-PD controls (adjusted mortality rate ratio: 1.14; 95% CI: 1.03 to 1.19). Adjusted mortality rates per 1000 person-years at risk for people with PD approximately doubled in the 5 years following diagnosis from 43 (95% CI: 38 to 48) to 75 (95% CI: 64 to 85). Following adjustments for age, gender, and time since diagnosis, mortality rates between 2007 and 2016 declined more slowly for people with PD (2% per year; 95% CI: 0%-4%) compared to people without PD (5% per year; 95% CI: 3%-6%).

Conclusions: Whilst mortality in PD is only slightly increased overall, it gradually increases with advancing disease. There has been a decline in mortality in PD over time, but this decrease was less pronounced than that in the general population. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.

Citing Articles

Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis.

Cox E, Wade R, Hodgson R, Fulbright H, Phung T, Meader N Health Technol Assess. 2024; 28(30):1-187.

PMID: 39021200 PMC: 11331379. DOI: 10.3310/YDSL3294.


Update: Protective and risk factors for Parkinson disease.

Grotewold N, Albin R Parkinsonism Relat Disord. 2024; 125:107026.

PMID: 38879999 PMC: 11846500. DOI: 10.1016/j.parkreldis.2024.107026.


Trends in parkinson's disease mortality in China from 2004 to 2021: a joinpoint analysis.

Wang S, Jiang S, Wu J, Miao Y, Duan Y, Mu Z BMC Public Health. 2024; 24(1):1091.

PMID: 38641581 PMC: 11031848. DOI: 10.1186/s12889-024-18532-8.


Case-Fatality Rate in Parkinson's Disease: A Nationwide Registry Study.

Sipila J, Kaasinen V, Rautava P, Kyto V Mov Disord Clin Pract. 2024; 11(2):152-158.

PMID: 38386489 PMC: 10883402. DOI: 10.1002/mdc3.13948.


Update: Descriptive epidemiology of Parkinson disease.

Grotewold N, Albin R Parkinsonism Relat Disord. 2024; 120:106000.

PMID: 38233324 PMC: 10922566. DOI: 10.1016/j.parkreldis.2024.106000.


References
1.
Lewis J, Schinnar R, Bilker W, Wang X, Strom B . Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2006; 16(4):393-401. DOI: 10.1002/pds.1335. View

2.
Benedetti M, Maraganore D, Bower J, McDonnell S, Peterson B, Ahlskog J . Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord. 2001; 16(5):830-7. DOI: 10.1002/mds.1170. View

3.
Clarke C . Mortality from Parkinson's disease in England and Wales 1921-89. J Neurol Neurosurg Psychiatry. 1993; 56(6):690-3. PMC: 489621. DOI: 10.1136/jnnp.56.6.690. View

4.
Ebmeier K, Calder S, Crawford J, Stewart L, Besson J, Mutch W . Parkinson's disease in Aberdeen: survival after 3.5 years. Acta Neurol Scand. 1990; 81(4):294-9. DOI: 10.1111/j.1600-0404.1990.tb01558.x. View

5.
Morens D, Davis J, Grandinetti A, Ross G, Popper J, White L . Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology. 1996; 46(4):1044-50. DOI: 10.1212/wnl.46.4.1044. View